Featured News

 

Latest News

Pfizer to Organize for Future Growth
Pfizer to Organize for Future Growth
News   Jul 15, 2018

Pfizer Inc. announced it will organize the company into three businesses.

READ MORE

3D Structure of 1918 Influenza Recreated
3D Structure of 1918 Influenza Recreated
News   Jul 13, 2018

Researchers who specialize in visualizing molecular structures developed a 3D model based on the 1918 H1 pandemic influenza virus. They aimed to increase knowledge on virus-like particles which show promise as vaccine platform.

READ MORE

An Orange a Day Keeps Vision Condition Away
An Orange a Day Keeps Vision Condition Away
News   Jul 13, 2018

A new study has shown that people who regularly eat oranges are less likely to develop macular degeneration than people who do not eat oranges.

READ MORE

Survival Rates Double for Patients with Melanoma Brain Metastases Receiving Immunotherapy
Survival Rates Double for Patients with Melanoma Brain Metastases Receiving Immunotherapy
News   Jul 12, 2018

Checkpoint blockade immunotherapies significantly improve the survival of patients with melanoma brain metastases, according to a new study.

READ MORE

Trained to Turn on Themselves: Using Cancer Cells to Kill Cancer
Trained to Turn on Themselves: Using Cancer Cells to Kill Cancer
News   Jul 12, 2018

What if cancer cells could be re-engineered to turn against their own kind? A new study led by researchers at Brigham and Women's Hospital leverages the power of gene editing to take a critical step toward using cancer cells to kill cancer.

READ MORE

Immatics Enters into a Strategic Partnership with Genmab
Immatics Enters into a Strategic Partnership with Genmab
News   Jul 12, 2018

Immatics and Genmab to combine proprietary technologies to create transformative bispecific therapies against novel, proprietary tumor targets.

READ MORE

An Unexpected Twist in the Tumor Versus T Cell Battle
An Unexpected Twist in the Tumor Versus T Cell Battle
News   Jul 11, 2018

Researchers from the University of California San Diego have identified an unexpected mechanism that could help determine whether a cancer patient will respond to immunotherapy.

READ MORE

‘Danger Signals’ Immune Discovery Could Improve Vaccines for Infants & Newborns
‘Danger Signals’ Immune Discovery Could Improve Vaccines for Infants & Newborns
News   Jul 11, 2018

Scientists have just identified a class of 'danger signals' that are highly efficient at triggering an immune response in infants and newborns. The discovery may have the potential to reduce both the age of vaccine administration and the need for multiple booster injections in infants and newborns, whose immune systems operate differently to those of adults.

READ MORE

Llama-Derived Nanobody Could Be Used to Tackle Hard-to-Treat Diseases
Llama-Derived Nanobody Could Be Used to Tackle Hard-to-Treat Diseases
News   Jul 10, 2018

Researchers from Case Western Reserve University School of Medicine have found a nanobody that holds promise to advance targeted therapies for a number of neurological diseases and cancer.

READ MORE

Antibody Drug May Be Effective Against Broader Class of Brain Cancers
Antibody Drug May Be Effective Against Broader Class of Brain Cancers
News   Jul 10, 2018

A new study explains why a particular mutation in the epidermal growth factor receptor (EGFR) results in more aggressive tumors and poorer overall survival of patients diagnosed with the brain cancer glioblastoma multiforme (GBM).

READ MORE

 
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy